Ferroptosis in Alzheimer’s Disease: The Regulatory Role of Glial Cells
Journal of Integrative Neuroscience · 24.04.2025 · 24 (4)
DOI: 10.31083/jin25845 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Integrative Neuroscience, online erschienen am 24.04.2025. Verfasst von Jingyi Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Ca…. Hauptthemen laut MEDLINE: Ferroptosis, Alzheimer Disease, Neuroglia, Iron. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 231 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China, Sichuan Science and Technology Program.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by the formation of amyloid plaques, neurofibrillary tangles and progressive cognitive decline. Amyloid-beta peptide (Aβ) monoclonal antibody therapeutic clinical trials have nearly failed, raising significant concerns about other etiological hypotheses about AD. Recent evidence suggests that AD patients also exhibit persistent neuronal loss and neuronal death accompanied by brain iron deposition or overload-related oxidative stress. Ferroptosis is a type of cell death that depends on iron, unlike autophagy and apoptosis. Inhibiting neuronal ferroptosis function is effective in improving cognitive impairment in AD. Notably, new research shows that ferroptosis in AD is crucially dependent on glial cell activation. This review examines the relationship between the imbalance of iron metabolism, the regulation of iron homeostasis in glial cells and neuronal death in AD pathology. Finally, the review summarizes some current drug research in AD targeting iron homeostasis, many novel iron-chelating compounds and natural compounds showing potential AD-modifying properties that may provide therapeutic targets for treating AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, 646000 Luzhou, Si…
- Department of Neurosurgery, The Affiliated Hospital of Southwest Medical University, 646000 Luzhou, Sichuan, China.
- Laboratory of Neurological Diseases and Brain Function, Institute of Epigenetics and Brain Science, The Affiliated Hospital of Southwest Medical University, 646000 Luzhou, Sichuan, China.
- Department of Human Anatomy and Histoembryology, School of Basic Medical Sciences, Southwest Medical University, 646000 Luzhou, Sichuan, China.
Förderung
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
- Sichuan Science and Technology Program
- Science and Technology Planning Project of Luzhou
- Ministry of Science and Technology of the People’s Republic of China
Zitieren
APA
Xu, J., Shen, R., Qian, M., Zhou, Z., Xie, B., Jiang, Y., Yu, Y., & Dong, W. (2025). Ferroptosis in Alzheimer’s Disease: The Regulatory Role of Glial Cells. Journal of Integrative Neuroscience, 24(4). https://doi.org/10.31083/jin25845
Vancouver
Xu J, Shen R, Qian M, Zhou Z, Xie B, Jiang Y, et al. Ferroptosis in Alzheimer’s Disease: The Regulatory Role of Glial Cells. Journal of Integrative Neuroscience. 2025;24(4). doi:10.31083/jin25845
BibTeX
@article{Xu2025,
author = {Xu, Jingyi and Shen, Rongjing and Qian, Mengting and Zhou, Zhengjun and Xie, Bingqing and Jiang, Yong and Yu, Yang and Dong, Wei},
title = {Ferroptosis in Alzheimer’s Disease: The Regulatory Role of Glial Cells},
journal = {Journal of Integrative Neuroscience},
year = {2025},
volume = {24},
number = {4},
doi = {10.31083/jin25845}
}
EUVIMED